Aine P Mckenzie, MD | |
4031 W Plano Pkwy, Suite 100, Plano, TX 75093-5619 | |
(972) 985-1072 | |
(972) 596-5382 |
Full Name | Aine P Mckenzie |
---|---|
Gender | Female |
Speciality | Physical Medicine And Rehabilitation |
Experience | 26 Years |
Location | 4031 W Plano Pkwy, Plano, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285829176 | NPI | - | NPPES |
8CR154 | Other | TX | BCBS TX 02/01/2011 |
M6284 | Other | TX | TEXAS MEDICAL BOARD |
TXB117532 | Other | TX | MEDICARE PART B - EFFECT 02/01/2011 |
P00913355 | Other | TX | MEDICARE RAILROAD - EFFECT 02/01/2011 |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | M6284 (Texas) | Primary |
2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | M6284 (Texas) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Orthotexas Physicians And Surgeons, Pllc | 3375724792 | 35 |
News Archive
Researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH), have identified a promising new target for autoimmune disease treatment - a cell-surface receptor called DR3.
Teduglutide is an analog of glucagon-like peptide 2 (GLP-2), a naturally occurring hormone that regulates the growth, proliferation and maintenance of cells lining the gastrointestinal tract. Teduglutide has been shown in animal studies and previous human clinical trials to increase the size and number of these cells, thereby increasing the absorptive surface area of the intestines.
(U.S. Physical Therapy) The American Physical Therapy Association (APTA) reported on its website (APTA.org) on Friday, February 26, 2010 that "The Centers for Medicare and Medicaid Services (CMS) announced that it will hold claims for the first 10 business days of March. The hold will apply to claims with dates of service of March 1, 2010 through March 12, 2010. Claims with dates of service of January 1, 2010-February 28, 2010 will continue to be paid based on the 0% update approved by Congress.
Azur Pharma Limited today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
› Verified 8 days ago
Entity Name | Orthotexas Physicians And Surgeons, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740590066 PECOS PAC ID: 3375724792 Enrollment ID: O20110217000911 |
News Archive
Researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH), have identified a promising new target for autoimmune disease treatment - a cell-surface receptor called DR3.
Teduglutide is an analog of glucagon-like peptide 2 (GLP-2), a naturally occurring hormone that regulates the growth, proliferation and maintenance of cells lining the gastrointestinal tract. Teduglutide has been shown in animal studies and previous human clinical trials to increase the size and number of these cells, thereby increasing the absorptive surface area of the intestines.
(U.S. Physical Therapy) The American Physical Therapy Association (APTA) reported on its website (APTA.org) on Friday, February 26, 2010 that "The Centers for Medicare and Medicaid Services (CMS) announced that it will hold claims for the first 10 business days of March. The hold will apply to claims with dates of service of March 1, 2010 through March 12, 2010. Claims with dates of service of January 1, 2010-February 28, 2010 will continue to be paid based on the 0% update approved by Congress.
Azur Pharma Limited today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Aine P Mckenzie, MD 4031 W Plano Pkwy, Suite 100, Plano, TX 75093-5619 Ph: (972) 985-1072 | Aine P Mckenzie, MD 4031 W Plano Pkwy, Suite 100, Plano, TX 75093-5619 Ph: (972) 985-1072 |
News Archive
Researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH), have identified a promising new target for autoimmune disease treatment - a cell-surface receptor called DR3.
Teduglutide is an analog of glucagon-like peptide 2 (GLP-2), a naturally occurring hormone that regulates the growth, proliferation and maintenance of cells lining the gastrointestinal tract. Teduglutide has been shown in animal studies and previous human clinical trials to increase the size and number of these cells, thereby increasing the absorptive surface area of the intestines.
(U.S. Physical Therapy) The American Physical Therapy Association (APTA) reported on its website (APTA.org) on Friday, February 26, 2010 that "The Centers for Medicare and Medicaid Services (CMS) announced that it will hold claims for the first 10 business days of March. The hold will apply to claims with dates of service of March 1, 2010 through March 12, 2010. Claims with dates of service of January 1, 2010-February 28, 2010 will continue to be paid based on the 0% update approved by Congress.
Azur Pharma Limited today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
› Verified 8 days ago
Dr. Sheena Bhuva, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6020 W Parker Rd Ste 200, Plano, TX 75093 Phone: 972-608-5000 | |
Maria C. Espejo, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy Ste 120, Plano, TX 75024 Phone: 217-779-5088 | |
Nayan Raman Patel, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6020 W Parker Rd, Suite 200, Plano, TX 75093 Phone: 972-608-5000 Fax: 972-608-5020 | |
Jocelyn Brooke Miller, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3700 W 15th St Ste 200b, Plano, TX 75075 Phone: 972-398-0261 | |
Mrs. Elizabeth Eversull, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5944 W Parker Rd, #400, Plano, TX 75093 Phone: 972-309-2021 Fax: 972-309-2023 | |
Dr. Manu Gupta, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3325 W Plano Pkwy, Plano, TX 75075 Phone: 972-379-0000 | |
Zair Shah, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2800 W 15th St, Plano, TX 75075 Phone: 972-612-9000 |